The MO HealthNet Division recently issued a new COVID vaccine provider bulletin.
Also in Missouri, the Department of Commerce’s Department of Health, and Senior Services (DHSS) and Insurance issued a new Standing Order for COVID tests provided by pharmacies. DHSS’s previously issued Standing Orders are available here.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The New York State COVID-19 Vaccine Team has recently updated its Guidance for the NYS COVID-19 Vaccination Program for individuals 12 years of age and older. The updates reflect the recent CDC changes in COVID-19 vaccine clinical guidance. The updates include:
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
Executive Order No. 21-18 Continued Waivers to Facilitate Hospital Planning and Ensure Additional HealthCare Workforce Capacity expired on March 31. Executive Order No. 21-18 extended Executive Order 21-15 Further Health Care Workforce Capacity that permitted pharmacists to have any number of pharmacist interns and pharmacy technicians under their supervision when administering vaccinations. Beginning April 1, the ratio reverts to pre-pandemic levels.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Statewide standing orders issued by Dr. Betsey Tilson, State Health Director, for the administration of nicotine replacement, contraceptives, post-exposure prophylaxis medications for the prevention of human immunodeficiency virus (HIV), glucagon for the treatment of severe hypoglycemia, naloxone and COVID related treatments have been updated, organized, and can be found here.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
The Board of Pharmacy’s temporary new address 3812 N. Santa Fe, Suite 300 in Oklahoma City. All upcoming Board meetings will be held at the new location.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Board of Pharmacy adopted the following:
Also in Oregon, the Board of Pharmacy posted its agenda and meeting materials for its next meeting scheduled for April 13-15.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Notice from TennCare, prior authorization (PA) requirements can be bypassed for certain medications when specific medical conditions exist. Those specific medications and diagnoses can be found here. Prescribers are encouraged to include the applicable diagnosis code on written prescriptions for inclusion on the electronic pharmacy claim. The submitted claim should include a Diagnosis Code Qualifier (Field # 492- WE) of “02,” indicating ICD-10, as well as the appropriate Diagnosis Code (Field # 424-DO). Note: A list of the preferred agents and the clinical criteria can be found here.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
The Board of Pharmacy (TSBP) issued a reminder notice on the proper destruction and disposal of prescription medications. For dangerous drugs destruction, a TSBP licensed pharmacist is authorized to destroy stock so that it is unfit for human consumption and disposed of in compliance with all applicable state and federal requirements.
Also in Texas, TSBP’s COVID website includes a chart comparing the authorizations in the PREP Act amendments with the Texas statutes and rules.
Finally in Texas, the Health, and Human Services Commission’s (HHSC) Vendor Drug Program (VDP) issued the biannual specialty drug list. Members should contact vdp-formulary@hhsc.state.tx.us with comments or any questions.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The Department of Vermont Health Access (DVHA) is implementing changes to its prescription drug benefits programs to ensure Medicaid patients continue to have access to the medications they need for conditions related to COVID-19. The changes center around copayments, prescription instructions, and approved medication treatments.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.